Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Short-term effect of removal of fixed orthodontic appliances on gingival health and subgingival microbiota: a prospective cohort study.

Yáñez-Vico RM, Iglesias-Linares A, Ballesta-Mudarra S, Ortiz-Ariza E, Solano-Reina E, Perea EJ.

Acta Odontol Scand. 2015;73(7):496-502. doi: 10.3109/00016357.2014.993701. Epub 2015 Jan 29.

PMID:
25631494
2.

[Fresh versus pasteurized yogurt: comparative study of the effects on microbiological and immunological parameters, and gastrointestinal comfort].

Ballesta S, Velasco C, Borobio MV, Argüelles F, Perea EJ.

Enferm Infecc Microbiol Clin. 2008 Nov;26(9):552-7. Spanish.

PMID:
19100174
3.

Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Cueto Md, Gálvez J, Perea EJ, Pascual A.

Clin Microbiol Infect. 2008 Feb;14(2):180-3. Epub 2007 Nov 15.

4.

Intracellular penetration and activity of DX-619 in human polymorphonuclear leukocytes.

García I, Ballesta S, Murillo C, Perea EJ, Pascual A.

Antimicrob Agents Chemother. 2006 Sep;50(9):3173-4.

5.

Detection of hypermutable Escherichia coli strains in a collection of clinical isolates by the fosfomycin-rifampin disk method.

Carmen Conejo M, Amblar G, Pascual A, Perea EJ, Martínez-Martínez L.

J Clin Microbiol. 2006 Jul;44(7):2672. No abstract available.

6.

[Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia].

del Toro MD, Rodríguez-Baño J, Martínez-Martínez L, Pascual A, Pérez-Canoa R, Perea EJ, Muniain MA.

Enferm Infecc Microbiol Clin. 2006 Jan;24(1):4-9. Spanish.

PMID:
16537055
7.

Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.

Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, Pascual A.

Clin Infect Dis. 2006 Jan 1;42(1):37-45. Epub 2005 Nov 29.

8.

Zinc eluted from siliconized latex urinary catheters does not affect the in vitro activity of antifungal agents against Candida spp.

Conejo MC, Ballesta S, García I, Perea EJ, Pascual A.

Int J Antimicrob Agents. 2005 Jul;26(1):96-8. No abstract available.

PMID:
15964744
9.

Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes.

Ballesta S, García I, Perea EJ, Pascual A.

J Antimicrob Chemother. 2005 May;55(5):785-7. Epub 2005 Apr 11.

PMID:
15824095
10.

[Oral microbiology in the era of genomics and proteomics].

Perea EJ.

Enferm Infecc Microbiol Clin. 2005 Mar;23(3):113-5. Spanish. No abstract available.

PMID:
15757580
11.

Oral flora in the age of molecular biology.

Perea EJ.

Med Oral Patol Oral Cir Bucal. 2004;9 Suppl:6-10; 1-5. English, Spanish.

12.

Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system.

de Cueto M, Ceballos E, Martinez-Martinez L, Perea EJ, Pascual A.

J Clin Microbiol. 2004 Aug;42(8):3734-8.

13.

Cytomegalovirus mononucleosis as a cause of prolonged fever and prominent weight loss in immunocompetent adults.

Rodríguez-Baño J, Muniain MA, Borobio MV, Corral JL, Ramírez E, Perea EJ, Perez-Cano R.

Clin Microbiol Infect. 2004 May;10(5):468-70.

14.

Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Rodríguez-Baño J, Navarro MD, Romero L, Martínez-Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A.

J Clin Microbiol. 2004 Mar;42(3):1089-94.

15.

[In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii].

Fernández Cuenca F, Pascual A, Martínez Martínez L, Perea EJ.

Rev Esp Quimioter. 2003 Jun;16(2):204-8. Spanish.

16.

Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.

Ballesta S, Pascual A, García I, Perea EJ.

Chemotherapy. 2003 Jul;49(4):163-6.

PMID:
12886050
17.

Evaluation of the WIDER I system for antimicrobial susceptibility testing of clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae.

Fernández-Cuenca F, Martínez-Martínez L, Pascual A, De Cueto M, Gutiérrez O, Nieto J, Perea EJ.

Clin Microbiol Infect. 2003 May;9(5):449-52.

18.

Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes.

García I, Pascual A, Ballesta S, del Castillo C, Perea EJ.

J Antimicrob Chemother. 2003 Jul;52(1):24-8. Epub 2003 Jun 12.

PMID:
12805263
19.

Evaluation of SDS-polyacrylamide gel systems for the study of outer membrane protein profiles of clinical strains of Acinetobacter baumannii.

Cuenca FF, Pascual A, Martínez Marínez L, Conejo MC, Perea EJ.

J Basic Microbiol. 2003;43(3):194-201.

PMID:
12761770
20.

[Acinetobacter baumannii bacteremia: clinical and prognostic features].

Rodríguez-Baño J, Pascual A, Gálvez J, Muniain MA, Ríos MJ, Martínez-Martínez L, Pérez-Cano R, Perea EJ.

Enferm Infecc Microbiol Clin. 2003 May;21(5):242-7. Spanish.

PMID:
12732114
21.

In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.

Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Perea EJ.

Chemotherapy. 2003 May;49(1-2):24-6.

PMID:
12714805
22.

Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.

Conejo Mdel C, Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ.

Antimicrob Agents Chemother. 2003 Apr;47(4):1403-6.

23.

Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.

Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ, Pascual A.

J Antimicrob Chemother. 2003 Mar;51(3):565-74.

PMID:
12615856
24.

Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells.

Pascual A, Ballesta S, García I, Perea EJ.

Antimicrob Agents Chemother. 2002 Dec;46(12):4013-5.

25.

In vitro adherence of Enterococcus faecalis and Enterococcus faecium to plastic biomaterials.

Joyanes P, Pascual A, Martínez-Martínez L, Hevia A, Perea EJ.

Clin Microbiol Infect. 1999 Jun;5(6):382-386. No abstract available.

26.

[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].

Pascual A A, Joyanes P, Martínez-Martínez L, del Carmen Conejo M, Hernández G, Chaves J, Perea EJ.

Enferm Infecc Microbiol Clin. 2001 Nov;19(9):432-4. Spanish.

PMID:
11709121
27.
28.

Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.

Martínez-Martínez L, Joyanes P, Suárez AI, Perea EJ.

Antimicrob Agents Chemother. 2001 Aug;45(8):2390-2.

29.

Uptake and intracellular activity of ketolide HMR 3647 in human phagocytic and non-phagocytic cells.

Pascual A, Ballesta S, García I, Perea EJ.

Clin Microbiol Infect. 2001 Feb;7(2):65-9.

30.

Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.

Martínez-Martínez L, Fernández F, Perea EJ.

J Antimicrob Chemother. 1999 Feb;43(2):277-9. Erratum in: J Antimicrob Chemother 1999 Aug;44(2):307.

PMID:
11252335
31.

[False resistance to imipenem in gram negative bacilli with and automatized system].

Fernández F, Martínez L, Pascual A, Perea EJ.

Enferm Infecc Microbiol Clin. 2000 Dec;18(10):500-5. Spanish.

PMID:
11198000
32.

Detection of resistant mutations in the reverse transcriptase of HIV-1-infected children.

Palomares JC, Perea EJ, Terrero E, Torres MJ, García ML, Romero J, Alejo A.

Clin Microbiol Infect. 2000 May;6(5):268-70. No abstract available.

33.

[Comparison of the activity of different macrolides on strains of Haemophilus influenzae].

Ramírez de Arellano JA, Perea EJ.

Rev Esp Quimioter. 2000 Sep;13(3):291-6. Spanish.

PMID:
11086280
34.

Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes.

García I, Pascual A, Ballesta S, Joyanes P, Perea EJ.

Antimicrob Agents Chemother. 2000 Nov;44(11):3193-5.

35.

Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.

Martínez-Martínez L, Conejo MC, Pascual A, Hernández-Allés S, Ballesta S, Ramírez De Arellano-Ramos E, Benedí VJ, Perea EJ.

Antimicrob Agents Chemother. 2000 Sep;44(9):2534-6.

36.

Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.

García I, Pascual A, Ballesta S, Perea EJ.

Int J Antimicrob Agents. 2000 Aug;15(3):201-5.

PMID:
10926442
37.

In vitro adherence of Enterococcus faecalis and Enterococcus faecium to urinary catheters.

Joyanes P, Pascual A, Martínez-Martínez L, Hevia A, Perea EJ.

Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):124-7.

PMID:
10746500
38.

Trends in the susceptibilities of Proteus mirabilis isolates to quinolones.

Hernández JR, Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ.

J Antimicrob Chemother. 2000 Mar;45(3):407-8. No abstract available.

PMID:
10702570
39.

[Who can be the author of an article?].

Perea EJ.

Enferm Infecc Microbiol Clin. 1999 Dec;17(10):485-8. Review. Spanish. No abstract available.

PMID:
10650642
40.

[Levofloxacin, in vitro activity].

Perea EJ.

Enferm Infecc Microbiol Clin. 1999;17 Suppl 1:8-13. Review. Spanish. No abstract available.

PMID:
10563104
41.

In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes.

Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ.

J Antimicrob Chemother. 1999 Jun;43 Suppl C:27-32.

PMID:
10404334
42.

[Ticks and Lyme disease in Lanzarote].

Pascual-Velasco F, Borobio MV, Carranza R, Perea EJ.

Enferm Infecc Microbiol Clin. 1999 Jan;17(1):45. Spanish. No abstract available.

PMID:
10069117
43.

Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations.

Martínez-Martínez L, Pascual A, Conejo MC, Picabea L, Perea EJ.

Antimicrob Agents Chemother. 1999 Feb;43(2):397-9.

44.

[Clinical microbiology: a specialty in crisis?].

Perea EJ.

Enferm Infecc Microbiol Clin. 1998 Dec;16(10):445-8. Spanish. No abstract available.

PMID:
9918988
45.

[Opsonin requirements for phagocytosis of Enterococcus spp. by human polymorphonuclear leukocytes].

García I, Joyanes P, Pascual A, Martínez-Martínez L, Perea EJ.

Enferm Infecc Microbiol Clin. 1998 Nov;16(9):419-22. Spanish.

PMID:
9887629
46.

Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.

Pascual A, García I, Ballesta S, Perea EJ.

Antimicrob Agents Chemother. 1999 Jan;43(1):12-5.

47.

The association of false-positive rapid plasma reagin results and HIV infection.

Joyanes P, Borobio MV, Arquez JM, Perea EJ.

Sex Transm Dis. 1998 Nov;25(10):569-71.

PMID:
9858355
48.

In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ.

Antimicrob Agents Chemother. 1998 Dec;42(12):3290-2.

49.

[The activity of the macrolides on Haemophilus influenzae: a critical review].

Perea EJ.

Med Clin (Barc). 1998 Feb;110 Suppl 1:60-4. Review. Spanish. No abstract available.

PMID:
9717163
50.

[Laboratory control in diagnosis and treatment of infective endocarditis].

Pascual A, Perea EJ.

Rev Esp Cardiol. 1998;51 Suppl 2:22-8. Spanish.

Supplemental Content

Loading ...
Support Center